Zydus Lifesciences Ltd Annually Results

Gross Sales

22,573.8

19,021.5

16,877.8

14,827.6

14,125

Excise Duty

0

0

0

0

0

Net Sales

22,573.8

19,021.5

16,877.8

14,827.6

14,125

Other Operating Income

667.7

525.9

359.6

282.3

278.5

Other Income

269.5

307.1

186.6

2,583.1

45.6

Total Income

23,511

19,854.5

17,424

17,693

14,449.1

Total Expenditure

16,402.6

14,177.3

13,986.3

11,769.2

11,289.5

PBIDT

7,108.4

5,677.2

3,437.7

5,923.8

3,159.6

Interest

165.9

81.2

129.9

127

158.8

PBDT

6,942.5

5,596

3,307.8

5,796.8

3,000.8

Depreciation

915.8

764.1

722.7

713

669.6

Minority Interest Before NP

0

0

0

0

0

Tax

2,049.3

1,492.6

690.4

441.5

453

Deferred Tax

-637.4

-515.1

-102.6

70.2

-259.4

Reported Profit After Tax

4,614.8

3,854.4

1,997.3

4,572.1

2,137.6

Minority Interest After NP

147.1

113.3

131.6

131

51.4

Net Profit after Minority Interest

4,525.5

3,859.5

1,960.3

4,487.3

2,133.6

Extra-ordinary Items

-144.93

4.39

-447.72

2,338.08

-234.37

Adjusted Profit After Extra-ordinary item

4,670.43

3,855.11

2,408.02

2,149.22

2,367.97

EPS (Unit Curr.)

44.97

38.14

19.3

43.84

20.85

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,100

300

600

250

350

Equity

100.6

100.6

101.2

102.4

102.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.48

29.84

20.36

39.95

22.36

PBDTM(%)

30.75

29.41

19.59

39.09

21.24

PATM(%)

20.44

20.26

11.83

30.83

15.13